We are live on ! Find out more
KFO

Kopp Family Office Portfolio holdings

AUM $163M
1-Year Est. Return 22.57%
This Fund
S&P 500
This Quarter Est. Return
-23.15%
1 Year Est. Return
+22.57%
3 Year Est. Return
+33.98%
5 Year Est. Return
+1.93%
10 Year Est. Return
–
AUM
$142M
AUM Growth
-$42.7M
Cap. Flow
+$1.73M
Cap. Flow %
1.22%
Top 10 Hldgs %
99.91%
Holding
14
New
–
Increased
6
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$826K
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$634K
3
JAMF
Jamf
JAMF
+$192K
4
MITK icon
Mitek Systems
MITK
+$148K
5
NEO icon
NeoGenomics
NEO
+$11.9K

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$75K
2
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$4.13K

Sector Composition

Rank Sector Weight
1 Healthcare 49.51%
2 Technology 23.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$43.4M 30.48%
544,043
-792
-0.1% -$75K
IEFA icon
2
iShares Core MSCI EAFE ETF
IEFA
$190B
$23M 16.15%
390,722
+9,875
+3% +$634K
FIVN icon
3
FIVE9
FIVN
$2.11B
$15.9M 11.17%
174,478
+8,168
+5% +$826K
JAMF
4
DELISTED
Jamf
JAMF
$15.4M 10.81%
621,243
+6,833
+1% +$192K
IEMG icon
5
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$15M 10.5%
304,745
-80
-0% -$4.13K
VCEL icon
6
Vericel Corp
VCEL
$2.35B
$13.9M 9.78%
552,973
+48
+0% +$1.42K
NEO icon
7
NeoGenomics
NEO
$1.96B
$13.2M 9.25%
1,615,513
+1,250
+0.1% +$11.9K
MITK icon
8
Mitek Systems
MITK
$754M
$2.32M 1.63%
251,055
+13,927
+6% +$148K
ISTB icon
9
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.11B
$106K 0.07%
2,228
– –
IVV icon
10
iShares Core S&P 500 ETF
IVV
$878B
$89K 0.06%
234
– –
IAGG icon
11
iShares Core International Aggregate Bond Fund
IAGG
$10.9B
$43K 0.03%
862
– –
IMTB icon
12
iShares Core 5-10 Year USD Bond ETF
IMTB
$275M
$37K 0.03%
834
– –
IJH icon
13
iShares Core S&P Mid-Cap ETF
IJH
$122B
$28K 0.02%
610
– –
IJR icon
14
iShares Core S&P Small-Cap ETF
IJR
$109B
$16K 0.01%
169
– –

Similar funds

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
PCR
Potrero Capital Research San Francisco, California $163M AUM 79.07% 1-Year Est. Return
TCGDR
TB Capital Gestao de Recursos Rio De Janeiro $163M AUM 20.86% 1-Year Est. Return
IPWA
International Private Wealth Advisors San Diego, California $163M AUM 16.99% 1-Year Est. Return
IVGAI
Index Venture Growth Associates IV St. Helier, Jersey $163M AUM 54.88% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
GP
Gridiron Partners Wexford, Pennsylvania $164M AUM 3.31% 1-Year Est. Return
PWAM
Papamarkou Wellner Asset Management New York $164M AUM 25.23% 1-Year Est. Return

Kopp Family Office's Q2 2022 Portfolio in Review

As of Q2 2022, Kopp Family Office held 14 positions worth $142M, down 23% from $185M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. Kopp Family Office opened no new positions and made no exits, leaving the 14-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 53% a quarter earlier, followed by Technology.

  • Kopp Family Office added most to FIVE9 in Q2 2022, an estimated $826K increase.
  • Kopp Family Office's biggest Q2 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $75K.
  • Kopp Family Office's ten largest holdings make up 100% of its $142M portfolio in Q2 2022.
  • Kopp Family Office opened 0 new positions and closed 0 in Q2 2022.
  • Kopp Family Office's portfolio value fell 23% quarter-over-quarter to $142M.

Based on Kopp Family Office's 13F filing for Q2 2022, filed 16 Aug 2022.